Cytoreductive Therapy and Management of Polycythemia Vera

This chapter explores various cytoreductive therapies for polycythemia vera, focusing on hydroxyurea, interferon, and other alternatives, particularly for special populations like pregnant patients. It emphasizes management strategies, second-line treatments such as roxalitinib, and the importance of disease monitoring and transplantation considerations.